PRFX Stock Analysis: Buy, Sell, or Hold?
PRFX - PainReform Ltd. Ordinary Shares
$2.10
-0.01 (-0.47%)
▼
5d:
-11.02%
30d:
-24.73%
90d:
+227.2%
WAIT
LOW Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: Apr 06, 2026
2d
Get Alerted When PRFX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: PRFX is down 11.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: PRFX is down 11.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: PRFX is currently trading at $2.10, which is considered oversold relative to its 30-day fair value range of $2.20 to $2.90.
Technical Outlook: Technically, PRFX is in a strong uptrend. Immediate support is located at $1.80, while resistance sits at $2.63.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.00 (+471.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PRFX is in a strong uptrend. Immediate support is located at $1.80, while resistance sits at $2.63.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.00 (+471.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$2.20 -
$2.90
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 471.4% below Wall St target ($12.00)
- WARNING: Recommendation downgraded due to -11.0% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$2.20 -
$2.90
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.80
Resistance Level
$2.63
Current Trend
Strong Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Wall Street Target
$12.00
(+471.4%)
Share & Embed Analysis
Last updated: April 02, 2026 11:47 PM ET
Data refreshes hourly during market hours. Next update: 12:47 AM
Data refreshes hourly during market hours. Next update: 12:47 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRFX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$178 | 63 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$151 | 63 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$91 | 61 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 55 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 56 HOLD |
